1407993-01-4

Basic information

• Product Name: 4-phenylnaphtho[1',2':4,5]furo[2,3-b]pyridine-3,6-diol
• Synonyms: 4-phenylnaphtho[1',2':4,5]furo[2,3-b]pyridine-3,6-diol
• CAS NO: 1407993-01-4
• Molecular Weight: 327.339
• Mol File: 1407993-01-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-phenylnaphtho[1',2':4,5]furo[2,3-b]pyridine-3,6-diol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-phenylnaphtho[1',2':4,5]furo[2,3-b]pyridine-3,6-diol(1407993-01-4)
• EPA Substance Registry System: 4-phenylnaphtho[1',2':4,5]furo[2,3-b]pyridine-3,6-diol(1407993-01-4)

Safety Data

• Hazardous Substances Data: 1407993-01-4(Hazardous Substances Data)

Upstream product

• 76509-17-6 3-benzyloxypyridine 
• 109-00-2 3-HYDROXYPYRIDINE 
• 1407992-99-7 3-benzyloxy-4-phenylnaphtho[1',2':4,5]furo[2,3-b]pyridine-6-ol 
• 1029797-91-8 1-acetyl-3-benzyloxy-4-phenyl-1,4-dihydropyridine 

Relevant articles and documents

Novel protein kinase inhibitors related to tau pathology modulate tau protein-self interaction using a luciferase complementation assay

The current number of drugs available for the treatment of Alzheimer's disease (AD) is strongly limited and their benefit for therapy is given only in the early state of the disease. An effective therapy should affect those processes which mainly contribu